483
Ajanta Pharma LimitedFDA 483 - Ajanta Pharma Limited - June 22, 2019
Record Details
Ajanta Pharma Limited, a drug products manufacturer in Bharuch, Gujarat, India, was cited for significant deficiencies in its quality system and laboratory controls during an FDA inspection. Observations included a failure to thoroughly investigate market complaints regarding product odor and potential contamination, as well as inadequate oversight of contract laboratory data and a lack of testing for leachable and extractables in primary packaging components. These issues indicate a potential risk to product quality and patient safety.
Open in Dashboard
ID · 23118fab-e9e6-49e2-a00d-e4d36a5e883e